Aethlon Medical, Inc. Stock price

Equities

AEMD

US00808Y4061

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 04:30:00 2024-03-28 pm EDT 5-day change 1st Jan Change
1.68 USD -1.75% Intraday chart for Aethlon Medical, Inc. +1.20% -23.29%
Sales 2024 * - Sales 2025 * - Capitalization 4.4M
Net income 2024 * -12M Net income 2025 * -13M EV / Sales 2024 * -
Net cash position 2024 * - Net cash position 2025 * - EV / Sales 2025 * -
P/E ratio 2024 *
-0.32 x
P/E ratio 2025 *
-0.48 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 93.39%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.75%
1 week+1.20%
Current month-2.33%
1 month-2.89%
3 months-22.94%
6 months-20.38%
Current year-23.29%
More quotes
1 week
1.65
Extreme 1.65
1.85
1 month
1.61
Extreme 1.61
1.85
Current year
1.60
Extreme 1.6001
2.29
1 year
1.40
Extreme 1.4
7.20
3 years
1.40
Extreme 1.4
124.90
5 years
1.40
Extreme 1.4
137.52
10 years
1.40
Extreme 1.4
5 400.01
More quotes
Managers TitleAgeSince
Chief Executive Officer 67 08-01-08
Chief Tech/Sci/R&D Officer 64 -
Chief Operating Officer 54 18-06-18
Members of the board TitleAgeSince
Chief Executive Officer 67 08-01-08
Chairman 88 99-03-09
Chief Operating Officer 54 18-06-18
More insiders
Date Price Change Volume
24-03-28 1.68 -1.75% 14,918
24-03-27 1.71 -2.29% 6,749
24-03-26 1.75 +0.57% 7,815
24-03-25 1.74 +1.75% 51,279
24-03-22 1.71 +3.01% 16,059

Delayed Quote Nasdaq, March 28, 2024 at 04:30 pm EDT

More quotes
Aethlon Medical, Inc. (Aethlon) is a medical therapeutic company focused on developing the Hemopurifier, a clinical-stage immunotherapeutic device which is designed to combat cancer and life-threatening viral infections suppression, seed the spread of metastasis and inhibit the benefit of cancer therapies. The Hemopurifier is designed to deplete the presence of circulating tumor-derived exosomes that promote immune suppression. Hemopurifier helps to bind and clear multiple different glycosylated viruses, such as human immunodeficiency virus (HIV), hepatitis C virus (HCV), Dengue, West Nile, multiple strains of influenza, Ebola, Chikungunya, smallpox, monkeypox, multiple herpes viruses, a MERS-CoV related pseudovirus, and others. Hemopurifier is used as a device for two independent indications: the treatment of individuals with advanced or metastatic cancer and the treatment of life threating viruses that are not approved therapies.
More about the company
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
1.68 USD
Average target price
25.05 USD
Spread / Average Target
+1,391.07%
Consensus
  1. Stock
  2. Equities
  3. Stock Aethlon Medical, Inc. - Nasdaq